NASDAQ:ELAB Elevai Labs (ELAB) Stock Price, News & Analysis → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free ELAB Stock Alerts $0.66 -0.01 (-1.49%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.62▼$0.6850-Day Range$0.57▼$0.8052-Week Range$0.57▼$4.24Volume153,333 shsAverage Volume61,128 shsMarket Capitalization$11.42 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Get Elevai Labs alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About Elevai Labs Stock (NASDAQ:ELAB)Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.Read More ELAB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ELAB Stock News HeadlinesApril 27, 2024 | americanbankingnews.comShort Interest in Elevai Labs, Inc. (NASDAQ:ELAB) Increases By 66.1%April 25, 2024 | seekingalpha.comELAB Elevai Labs, Inc.April 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 22, 2024 | globenewswire.comELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 MonthsApril 20, 2024 | finance.yahoo.comElevai Labs, Inc. (ELAB)April 18, 2024 | americanbankingnews.comElevai Labs (NASDAQ:ELAB) Shares Down 1.8% April 2, 2024 | investorplace.comELAB Stock Earnings: Elevai Labs Reported Results for Q4 2023March 29, 2024 | globenewswire.comElevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial ResultsApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 20, 2024 | investing.comELEVAI launches consumer skincare portalMarch 18, 2024 | globenewswire.comElevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical MarketFebruary 2, 2024 | finanznachrichten.deFibroBiologics Announces Anticipated Listing DayFebruary 1, 2024 | investorplace.comWhy Is Elevai Labs (ELAB) Stock Up 57% Today?January 24, 2024 | finance.yahoo.comELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark OfficeJanuary 17, 2024 | msn.comELEVAI LABS reports preliminary total net revenue for 2023 of over $1.635MJanuary 17, 2024 | finance.yahoo.comELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global ReachJanuary 16, 2024 | investorplace.comWhy Is Elevai Labs (ELAB) Stock Up Today?January 16, 2024 | finanznachrichten.deElevai Labs Inc.: ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing TechnologyJanuary 16, 2024 | marketwatch.comElevai Labs Shares Double After Licensing Deal With INmune BioJanuary 2, 2024 | finance.yahoo.comELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry ConferencesDecember 12, 2023 | investorplace.comELAB Stock Earnings: Elevai Labs Reported Results for Q3 2024December 11, 2023 | finance.yahoo.comElevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023December 8, 2023 | morningstar.comElevai Labs Inc ELABDecember 7, 2023 | finance.yahoo.comELEVAI Labs, Inc. Expands International Distribution into EuropeNovember 29, 2023 | finance.yahoo.comElevai Labs Enters into Licensing Agreement with Yuva Biosciences to Combine Exosome and Mitochondrial Technologies to Develop New Aesthetics ProductsNovember 27, 2023 | investing.comElevai Labs Inc (ELAB)November 24, 2023 | finance.yahoo.comELEVAI Labs, Inc. Announces Closing of $6,000,000 Initial Public OfferingSee More Headlines Receive ELAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Elevai Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/29/2024Today4/27/2024Next Earnings (Estimated)7/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:ELAB Previous SymbolNASDAQ:ELAB CUSIPN/A CIK1840563 Webelevaiskincare.com Phone866-794-4940FaxN/AEmployees16Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio3.79 Quick Ratio3.41 Sales & Book Value Annual Sales$1.71 million Price / Sales6.68 Cash FlowN/A Price / Cash FlowN/A Book Value$0.22 per share Price / Book3.00Miscellaneous Outstanding Shares17,330,000Free FloatN/AMarket Cap$11.42 million OptionableN/A BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDr. Jordan R. Plews Ph.D. (Age 40)Co-Founder, President, CEO & Director Comp: $200kMs. Brenda Buechler (Age 53)Chief Marketing Officer Comp: $190kMr. Christoph Kraneiss (Age 52)Chief Commercial Officer Comp: $180kDr. Hatem Abou-Sayed F.A.C.S. (Age 52)FACS, M.B.A., M.D., MBA, Co-Founder, Chief Medical Officer & Director Mr. Graydon Bensler C.F.A. (Age 32)CFO, Secretary & Director Key CompetitorsAlterity TherapeuticsNASDAQ:ATHEGuardion Health SciencesNASDAQ:GHSIGalera TherapeuticsNASDAQ:GRTXMoleculin BiotechNASDAQ:MBRXAeterna ZentarisNASDAQ:AEZSView All Competitors ELAB Stock Analysis - Frequently Asked Questions How have ELAB shares performed in 2024? Elevai Labs' stock was trading at $1.8282 at the beginning of 2024. Since then, ELAB stock has decreased by 63.9% and is now trading at $0.6592. View the best growth stocks for 2024 here. Are investors shorting Elevai Labs? Elevai Labs saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 54,800 shares, an increase of 66.1% from the March 31st total of 33,000 shares. Based on an average daily volume of 662,400 shares, the short-interest ratio is currently 0.1 days. View Elevai Labs' Short Interest. When is Elevai Labs' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, July 5th 2024. View our ELAB earnings forecast. How were Elevai Labs' earnings last quarter? Elevai Labs, Inc. (NASDAQ:ELAB) announced its quarterly earnings results on Friday, March, 29th. The company reported ($0.08) earnings per share (EPS) for the quarter. The business had revenue of $0.70 million for the quarter. When did Elevai Labs IPO? Elevai Labs (ELAB) raised $6 million in an IPO on Tuesday, November 21st 2023. The company issued 1,500,000 shares at $4.00 per share. Univest Securities served as the underwriter for the IPO. When does Elevai Labs' lock-up period expire? Elevai Labs' lock-up period expires on Monday, May 20th. Elevai Labs had issued 1,500,000 shares in its public offering on November 21st. The total size of the offering was $6,000,000 based on an initial share price of $4.00. After the end of Elevai Labs' lock-up period, major shareholders and company insiders will be able to sell their shares of the company. How do I buy shares of Elevai Labs? Shares of ELAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ELAB) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevai Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
